Table 2 Baseline patient comorbidities
Parameter | N = 27 |
|---|---|
Asthma-related comorbidities, mean (SD) | 2 (1.5) |
Number of asthma-related comorbidities, n (%) | |
0 | 7 (25.9) |
1 | 1 (3.7) |
≥ 2 | 19 (70.4) |
Asthma-related comorbidities (frequency > 5%), n (%) | |
Allergic rhinitis | 12 (44.4) |
Nasal polyps | 11 (40.7) |
Gastroesophageal reflux disease | 11 (40.7) |
Chronic rhinosinusitis | 10 (37) |
Allergic conjunctivitis | 5 (18.5) |
Atopic dermatitis | 4 (14.8) |
Other relevant comorbidities (frequency > 5%), n (%) | |
Depression and anxiety | 10 (37) |
Obstructive sleep apnoea | 8 (29.6) |
Other diseases | 8 (29.6) |
Osteoporosis | 5 (18.5) |
Cardiovascular disease | 3 (11.1) |
Diabetes mellitus | 2 (7.4) |